Vagus nerve stimulation (VNS) is an effective alternative treatment for pat
ients with refractory epilepsy. The generator produces intermittent stimula
tion trains and does not require patient intervention. Using currently avai
lable technology, continuous stimulation is incompatible with a reasonable
battery life. Because earlier studies have demonstrated the persistence of
a stimulation effect after discontinuation of the stimulation train, we int
ended to evaluate the clinical efficacy of VNS in both the programmed inter
mittent stimulation mode and the magnet stimulation mode. Patients, compani
ons, and caregivers were instructed on how to administer additional stimula
tion trains when an aura or a seizure onset occurred. We assumed that patie
nts or caregivers could recognize habitual seizures and were able to evalua
te sudden interruption of these seizures. During a mean follow-up of 35 mon
ths, 46% of patients became responders, with a reduction in seizure frequen
cy of more than 50%. Twenty-nine percent of patients stopped having convuls
ive seizures. In two thirds of patients who were able to self-administer or
receive additional magnet stimulation, seizures could be interrupted consi
stently or occasionally. More than half of the patients who reported a posi
tive effect of magnet stimulation became responders. Only three patients we
re able to use the magnet themselves. In most cases, support from caregiver
s was necessary. This study is the first to document the efficacy of magnet
-induced VNS in a larger patient population during long-term follow-up. The
magnet is a useful tool that provides patients who are treated with VNS an
d mainly caregivers of such patients with an additional means of controllin
g seizures. To further confirm the self-reported results from our patients,
additional studies comparing programmed stimulation and magnet-induced sti
mulation during monitoring conditions are needed.